Scott H. Gillis
Mr. Gillis joined NUCRYST in 1999 at an important stage for the company. Through his leadership, NUCRYST entered into a collaborative agreement with Smith & Nephew for the global sale and distribution of Acticoat™ antimicrobial dressings. In 2001, NUCRYST diversified its direction to embrace pharmaceutical product development. Under his guidance, the company has grown from 57 to 130 employees, expanded its manufacturing twice, established a pharmaceutical research facility and placed its first drug into clinical trial. Mr. Gillis has more than 30 years experience in the pharmaceutical and medical device industry in capacities ranging from pharmaceutical sales to senior sales and marketing positions to general management with extensive experience in the fields of dermatology, anti-infective, cardiovascular, oncology, psychiatric, orthopedic and wound care products. His experience also includes the advancement of medical ideas from research and development to commercial products, sourcing and securing financing, and negotiating sales, marketing and distribution partnerships with major healthcare corporations. Prior to joining NUCRYST in 1999, Mr. Gillis served as President and CEO of Li Medical, a medical device company. Prior to Li Medical Mr. Gillis spent 15 years at Bristol-Myers Squibb where he worked in a number of divisions including Squibb, Westwood, Mead Johnson Pharmaceuticals, ConvaTec and Mead Johnson Oncology. At ConvaTec he served as Vice President and General Manager of ConvaTec USA and later as Global Vice President, Wound and Skin Care. A Boston native, Mr. Gillis has an MBA from Xavier University and a BA in Biology and Chemistry from Salem State College.